Exchange: NASDAQ·Updated 07:59 PM EDT
SLS logo

SLS SELLAS Life Sciences Group Inc

$11.34
$0.54
(4.54%)
Today
Closed $11.34
$0.01
(0.09%)
After Hours
EarningsNov 11
Mkt Cap$2.4B
Vol4.66M

About SLS

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.
48

Neutral Sentiment

How do you feel about SLS?

PawPawTine
$SLS Great news for me today. I just got my new CT scans. It’s been 5 years since my stage 3 stomach cancer diagnosis and I’m still cancer free. 5 years is a big deal. My most pessimistic “shovel ready” doctor said I’ve made it to the point where chances of reoccurrence is slim. BUT - 5 year survival odds for AML patients (especially cr2) are far less hopeful. (I lost my stepson to AML) And now thanks to SLS GPS, more and more will get the same great news I just did.
147
MarcoFla99
$SLS Why the Fu@K does everyone continue to speak about BioRich? Stop giving that DBag a platform. Block him and forget him. PLEASE
1
68
Cgwsc
$SLS 80th announced? Nope. Quiet Period still there? Yep. Booth still big? Oh yeah. Then I’m chilling
70
FatherofTrades
$SLS Wake me up when the 80th event occurs. None of this movement means much here. We are all just waiting.
61
thompske
$SLS share price has dropped for two days and sentiment is up. Can't make this sh*t up here...
1
49
Nasfact
$SLS totally normal behavior... There must be agreements going on and price is getting controlled, not allowed to break out in any direction... They are pretty busy as we speak IMO. 80 event does not matter anymore...it actually did not matter 3 month ago... No AI, no doctor, no analyst, nobody predicted this and that to means the destination and final letters of this company which did not extend its lease are written and set in stone. 2 major catalysts ahead and many catalysts around them are sealed until the case is getting opened and closed at the same time. What else do you wanna tell the people while sitting comfortably in your gigantic booth on one of the most valued exhibitits? Give me break! Patience for the Patients!
38
Duncan74
$SLS People screaming about shorts covering are completely missing the forest for the trees. The only metric that matters is surviving the volatility until the acquisition check clears.
36
HasbulaBuffetJr
$SLS Sold out of all the other stocks from my portfolio but this, because of the market and went all in here! This is the only stock I believe in now!
37
IUPwiggum
$SLS the SLS camp here seems divided on why the quiet period(s), the materialness of 80, and purpose of the booth. I have my theories, but I completely understand the other sides as well. In my humble opinion, the QP was brought on by the nearing of 80. But it seems we might have entered another QP for another reason. BO talks and NDA, possibly? I also firmly believe that the 80th is material due to the (mostly) buying and (lesser) selling of shares it would cause. Legally, it doesn’t represent success or failure, so not being material is also a valid point. I believe that SLS is most definitely going to use the booth to show off GPS, SLS009, or both, to attract buyers. The argument that it will be used to announce a buyout is also valid. I wanted 80, FA, then BO news, each raising the SP in steps. However, due to possible NDA, we might get a bundle of these all at once. If so, that’s great too, as it would not give shorts time to cover. Because f**k ‘em. #40billy #godzilla
32
DonnaFrog
$SLS for better or worse I bought some more. I am totally behind this and own more shares than I ever dreamed of owning. Small potatoes compared to some but a huge amount to me! 💎👐🏻💎and extremely
33
KemPharm_rocks
$SLS Just remember, as investors, we may be feeling frustrated with this long study tail, but consider what a boon this tail is for Stergiou and his staff, as they get more time to finalize the topline data for SLS009. 🙌🏻
35
biospeculator
$SLS So here we are. Based on Company communications and previous statements and the recent ASH news and rules, it all comes down imo to NOV. 4, 2026, at 9am when the embargo for ASH presentations is lifted. We should get topline results with a more in-depth results presentation during the conf. in December. Most likely a buyout previous to that date is also off the table unless a major panics and moves in with an offer to good to refuse. Based on the short position and FOMO as recently seen with MRNA and money coming out of the AI trade my target is a GME type of trade with a pps of up to $180. GLTA
32
HP18
$SLS This wait is no longer for the 80 event. There is something big happening behind the scenes..
32
SellasgpsCurativeBAT11
$SLS As a Biostatistician Sellas QP is related to ASH 2026 Embargo coupled with M&A. Abstracts submitted to ASH are subject to an embargo starting from the moment they are submitted. Sellas is a publicly traded company and is bound by SEC regulatory compliance to release limited topline data early, they must file an approved written request and legal counsel letter per ASH embargo rules. Longs, we will get a PR from Sellas stating they are presenting a late-breaking abstract at the American Society of Hematology (ASH) Annual Meeting in coming days/Hours. We are approaching biggest Catalyst in Sellas Corporate history. ✌️🙏❤️‍🩹
34
PureLifeH2O
$SLS 54 days Sterg… “The second half of 2026 is poised to be one of the most catalyst-rich period[s] in our company’s history.”
32
G_Trade
$SLS The battle is getting real. the market is fighting over uncertainty, but i’m focused on what comes next. REGAL is the defining catalyst, GPS is the opportunity, and SLS009 adds another dimension to the SELLAS story. a successful clinical outcome will trigger a massive, transformational revaluation of SELLAS and its entire oncology platform. we are not talking about an ordinary price move. we are talking about a fundamental shift in how the market values this company and its long-term potential. volatility is noise. clinical evidence changes everything. and beyond the market, the real mission is giving cancer patients better treatment options and more hope. SELLAS is approaching a defining moment. the science, the catalyst and the potential are coming together. the market will have to reassess the full picture.
31
CUMBERSUM
$SLS So we are still at 78 ….never in a million years would I believe it. The never ending trial.
29
LovelyMongsil
$SLS Watched very interesting YouTube talked about bio tech recent news and cancer immunotherapy discussed. Not English content so cannot link here. According to bio expert, Moderna cancer vaccine is so individually customized and difficult to make for every patient case, treatment fee is expected to as high as $600,000 per patient here in Japan or Korea. This is hard to believe.. On the hand, GPS will be real game changer for cancer vaccine and save huge patients in coming years and for ever.
1
25
Idfkytm
$SLS The longer we're range-bound, the larger the breakout will be. Give us the goods sterg.
28
Duncan74
$SLS Forget about the 56M short interest. It is just the structural arbitrage hedge for the 90M Long institutional stake. The institutions must and will play this risk-management / premium collection game until the data hits. They are managing paper volatility. We are playing the long game because we know the underlying math. Our endgame isn't daily penny-flipping or bear squeezing. Our endgame is the real, unblinded enterprise value of the assets. Hold the line. Don’t get shaken off 🤷‍♂️💎🙌🔓
1
27

Advertisement|Remove ads.